TRIN vs. CORZ, FHB, BUR, AVAL, AUB, BFH, CLSK, ENVA, PRK, and LU
Should you be buying Trinity Capital stock or one of its competitors? The main competitors of Trinity Capital include Core Scientific (CORZ), First Hawaiian (FHB), Burford Capital (BUR), Grupo Aval Acciones y Valores (AVAL), Atlantic Union Bankshares (AUB), Bread Financial (BFH), CleanSpark (CLSK), Enova International (ENVA), Park National (PRK), and Lufax (LU). These companies are all part of the "banking" industry.
Trinity Capital vs.
Core Scientific (NASDAQ:CORZ) and Trinity Capital (NASDAQ:TRIN) are both finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, community ranking, risk, profitability, institutional ownership, media sentiment, dividends, earnings and analyst recommendations.
Trinity Capital has a net margin of 40.73% compared to Core Scientific's net margin of 0.00%. Trinity Capital's return on equity of 15.90% beat Core Scientific's return on equity.
Trinity Capital has lower revenue, but higher earnings than Core Scientific. Core Scientific is trading at a lower price-to-earnings ratio than Trinity Capital, indicating that it is currently the more affordable of the two stocks.
24.6% of Trinity Capital shares are held by institutional investors. 32.0% of Core Scientific shares are held by company insiders. Comparatively, 6.4% of Trinity Capital shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
In the previous week, Core Scientific had 1 more articles in the media than Trinity Capital. MarketBeat recorded 8 mentions for Core Scientific and 7 mentions for Trinity Capital. Core Scientific's average media sentiment score of 0.64 beat Trinity Capital's score of 0.52 indicating that Core Scientific is being referred to more favorably in the media.
Trinity Capital received 4 more outperform votes than Core Scientific when rated by MarketBeat users. However, 70.00% of users gave Core Scientific an outperform vote while only 54.64% of users gave Trinity Capital an outperform vote.
Core Scientific currently has a consensus target price of $19.07, indicating a potential upside of 73.73%. Trinity Capital has a consensus target price of $15.17, indicating a potential downside of 4.45%. Given Core Scientific's stronger consensus rating and higher probable upside, equities analysts clearly believe Core Scientific is more favorable than Trinity Capital.
Summary
Core Scientific beats Trinity Capital on 10 of the 18 factors compared between the two stocks.
Get Trinity Capital News Delivered to You Automatically
Sign up to receive the latest news and ratings for TRIN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Trinity Capital Competitors List
Related Companies and Tools
This page (NASDAQ:TRIN) was last updated on 2/21/2025 by MarketBeat.com Staff
